Compare NBY & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBY | VCIG |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | | Diversified Commercial Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 7.5M |
| IPO Year | 2007 | 2023 |
| Metric | NBY | VCIG |
|---|---|---|
| Price | $1.07 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 116.4K | ★ 6.8M |
| Earning Date | 11-07-2025 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.47 | ★ 0.98 |
| Revenue | $10,302,000.00 | ★ $32,903,041.00 |
| Revenue This Year | $23.91 | N/A |
| Revenue Next Year | $32.05 | N/A |
| P/E Ratio | $41.19 | ★ $1.15 |
| Revenue Growth | ★ 390.34 | 24.77 |
| 52 Week Low | $0.46 | $0.89 |
| 52 Week High | $4.44 | $2,202.00 |
| Indicator | NBY | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 39.89 |
| Support Level | $1.00 | $0.91 |
| Resistance Level | $1.11 | $1.15 |
| Average True Range (ATR) | 0.09 | 0.16 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 84.28 | 39.52 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.